Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Background:

Ovarian cancer is a common gynecological malignant tumor in women. Most patients have reached the advanced stage when they visit the hospital. In order to diagnose ovarian cancer at an early stage, treat it at an early stage, and improve the survival rate of patients, this study has used the imaging computed tomography (CT) method to diagnose stage IA ovarian cancer.

Purpose:

The purpose of this work was to study CT features of stage IA ovarian cancer, and compare the borderline tumor and stage IC ovarian cancer at the same time so as to improve the CT diagnosis of early ovarian cancer.

Methods:

We retrospectively collected clinical and CT data of patients with stage I ovarian cancer and borderline ovarian tumor admitted to Nantong Tumor Hospital from 2013 to 2021. Altogether, 23 cases of patients (borderline ovarian tumor, 9 cases; stage IA ovarian cancer, 5 cases; stage IC ovarian cancer, 9 cases) were involved. CT characteristics of these patients were analyzed in terms of the tumor diameter, cystic solid structure, solid component, septation, enhancement, peritoneal thickening, ascites, and abdominal lymph nodes.

Results:

CT features of stage IA ovarian cancer included large tumor size (average diameter: 15 cm), cystic solid structure (4/5; 80%), septation (4/5; 80%), and enhanced cystic wall, septum, or solid components of the tumor on contrast-enhanced CT (5/5; 100%), no peritoneal thickening (0/5; 0%), no ascites (0/5; 0%), and no abdominal lymph node enlargement (0/5; 0%). The tumor structure did not differ significantly between stage IA and IC ovarian cancers ( > 0.05), while intraperitoneal ascites did (χ2 = 0.031; < 0.05). Stage IA and borderline ovarian tumors did not differ significantly in ovarian tumor structure ( > 0.05).

Conclusion:

CT features of stage IA ovarian cancer included large tumor size, cystic solid structure, septation, and enhanced cystic wall and solid parts in the tumors. No pelvic or abdominal metastasis was observed.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056251322231024071757
2023-10-31
2025-08-14
The full text of this item is not currently available.

References

  1. PalP. StarkweatherK.N. HalesK.H. HalesD.B. A review of principal studies on the development and treatment of epithelial ovarian cancer in the laying hen Gallus gallus.Comp. Med.202171427128410.30802/AALAS‑CM‑20‑00011634325771
    [Google Scholar]
  2. ArmstrongD.K. AlvarezR.D. Bakkum-GamezJ.N. BarroilhetL. BehbakhtK. BerchuckA. BerekJ.S. ChenL. CristeaM. DeRosaM. ElNaggarA.C. GershensonD.M. GrayH.J. HakamA. JainA. JohnstonC. LeathC.A.III LiuJ. MahdiH. MateiD. McHaleM. McLeanK. O’MalleyD.M. PensonR.T. Percac-LimaS. RatnerE. RemmengaS.W. SabbatiniP. WernerT.L. ZsirosE. BurnsJ.L. EnghA.M. NCCN guidelines insights: Ovarian cancer, version 1.2019.J. Natl. Compr. Canc. Netw.201917889690910.6004/jnccn.2019.003931390583
    [Google Scholar]
  3. JavadiS. GaneshanD.M. QayyumA. IyerR.B. BhosaleP. Ovarian cancer, the revised FIGO staging system, and the role of imaging.AJR Am. J. Roentgenol.201620661351136010.2214/AJR.15.1519927042752
    [Google Scholar]
  4. DuskaL.R. KohnE.C. The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.Ann. Oncol.201728S8viii8, viii1210.1093/annonc/mdx44529232468
    [Google Scholar]
  5. FalcettaF.S. LawrieT.A. MedeirosL.R. da RosaM.I. EdelweissM.I. SteinA.T. ZelmanowiczA. MoraesA.B. ZaniniR.R. RosaD.D. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.Cochrane Database Syst. Rev.20161010CD00534427737492
    [Google Scholar]
  6. ShaabanA. RezvaniM. Ovarian cancer: Detection and radiologic staging.Clin. Obstet. Gynecol.2009521739310.1097/GRF.0b013e318196162519179862
    [Google Scholar]
  7. ArmstrongD.K. AlvarezR.D. Bakkum-GamezJ.N. BarroilhetL. BehbakhtK. BerchuckA. ChenL. CristeaM. DeRosaM. EisenhauerE.L. GershensonD.M. GrayH.J. GrishamR. HakamA. JainA. KaramA. KonecnyG.E. LeathC.A. LiuJ. MahdiH. MartinL. MateiD. McHaleM. McLeanK. MillerD.S. O’MalleyD.M. Percac-LimaS. RatnerE. RemmengaS.W. VargasR. WernerT.L. ZsirosE. BurnsJ.L. EnghA.M. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology.J. Natl. Compr. Canc. Netw.202119219122610.6004/jnccn.2021.000733545690
    [Google Scholar]
  8. TrimbosJ.B. Surgical treatment of early-stage ovarian cancer.Best Pract. Res. Clin. Obstet. Gynaecol.201741607010.1016/j.bpobgyn.2016.10.00127894705
    [Google Scholar]
  9. SteinE.B. WasnikA.P. SciallisA.P. KamayaA. MaturenK.E. MR imaging–pathologic correlation in ovarian cancer.Magn. Reson. Imaging Clin. N. Am.201725354556210.1016/j.mric.2017.03.00428668159
    [Google Scholar]
  10. TsiliA.C. NakaC. ArgyropoulouM.I. Multidetector computed tomography in diagnosing peritoneal metastases in ovarian carcinoma.Acta Radiol.202162121696170610.1177/028418512098000633334121
    [Google Scholar]
  11. FolkinsA.K. LongacreT.A. Low-grade serous neoplasia of the female genital tract.Surg. Pathol. Clin.201912248151310.1016/j.path.2019.02.00631097112
    [Google Scholar]
  12. HackerN.F. RaoA. Surgery for advanced epithelial ovarian cancer.Best Pract. Res. Clin. Obstet. Gynaecol.201741718710.1016/j.bpobgyn.2016.10.00727884789
    [Google Scholar]
  13. GockleyA. PagaczK. FiasconeS. StawiskiK. HolubN. HasselblattK. CramerD.W. FendlerW. ChowdhuryD. EliasK.M. A translational model to improve early detection of epithelial ovarian cancers.Front. Oncol.20221278615410.3389/fonc.2022.78615435530324
    [Google Scholar]
  14. SteinE.B. RoselandM.E. ShampainK.L. WasnikA.P. MaturenK.E. Contemporary guidelines for adnexal mass imaging: A 2020 update.Abdom. Radiol.20214652127213910.1007/s00261‑020‑02812‑z33079254
    [Google Scholar]
  15. CuiL.W. ShenZ.Y. MRI appearances of stage IA ovarian carcinoma.Curr Med Imaging202310.2174/1573405619666230306102912
    [Google Scholar]
  16. BerekJ.S. KehoeS.T. KumarL. FriedlanderM. Cancer of the ovary, fallopian tube, and peritoneum.Int. J. Gynaecol. Obstet.2018143S2597810.1002/ijgo.1261430306591
    [Google Scholar]
  17. BerekJ.S. RenzM. KehoeS. KumarL. FriedlanderM. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.Int. J. Gynaecol. Obstet.2021155S1618510.1002/ijgo.1387834669199
    [Google Scholar]
  18. LimD. DoY. KwonB.S. ChangW. LeeM.S. KimJ. ChoJ.G. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer.BMB Rep.202053629129810.5483/BMBRep.2020.53.6.06032438972
    [Google Scholar]
  19. SkirnisdottirI. ÅkerudH. SeidalT. Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II.Int. J. Oncol.20185341633164210.3892/ijo.2018.451130066848
    [Google Scholar]
  20. GiatromanolakiA. SivridisE. TsikourasP. ManavisI. MaroulisG. KoukourakisM.I. Angiogenesis and vascular survival ability in ovarian adenocarcinomas.Virchows Arch.2004445552152610.1007/s00428‑004‑1089‑y15365829
    [Google Scholar]
  21. BentC.L. SahdevA. RockallA.G. SinghN. SohaibS.A. ReznekR.H. MRI appearances of borderline ovarian tumours.Clin. Radiol.200964443043810.1016/j.crad.2008.09.01119264189
    [Google Scholar]
  22. deSouzaN.M. O’NeillR. McIndoeG.A. DinaR. SoutterW.P. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.AJR Am. J. Roentgenol.20051843999100310.2214/ajr.184.3.0184099915728632
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056251322231024071757
Loading
/content/journals/cmir/10.2174/0115734056251322231024071757
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Borderline ovarian tumor; Computed tomography; Ovarian cancer; Stage IA; Stage IC
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test